APA (7th ed.) Citation

Henrykowska, G., Bartusik-Aebisher, D., Dynarowicz, K., Ramesh, T. S., Smolak, B., & Aebisher, D. (2026). Overcoming Resistance to Anti-EGFR Therapies: Mechanisms of Cetuximab and Panitumumab Resistance and Emerging Combination Strategies. Pharmaceuticals (14248247), 19(7), 1041. https://doi.org/10.3390/ph19071041

Chicago Style (17th ed.) Citation

Henrykowska, Gabriela, Dorota Bartusik-Aebisher, Klaudia Dynarowicz, Tamil Selvan Ramesh, Barbara Smolak, and David Aebisher. "Overcoming Resistance to Anti-EGFR Therapies: Mechanisms of Cetuximab and Panitumumab Resistance and Emerging Combination Strategies." Pharmaceuticals (14248247) 19, no. 7 (2026): 1041. https://doi.org/10.3390/ph19071041.

MLA (9th ed.) Citation

Henrykowska, Gabriela, et al. "Overcoming Resistance to Anti-EGFR Therapies: Mechanisms of Cetuximab and Panitumumab Resistance and Emerging Combination Strategies." Pharmaceuticals (14248247), vol. 19, no. 7, 2026, p. 1041, https://doi.org/10.3390/ph19071041.